Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioceres Crop Solutions (BIOX) Raw Materials (2017 - 2025)

Bioceres Crop Solutions' Raw Materials history spans 9 years, with the latest figure at $19.3 million for Q2 2025.

  • On a quarterly basis, Raw Materials fell 14.46% to $19.3 million in Q2 2025 year-over-year; TTM through Jun 2025 was $19.3 million, a 14.46% decrease, with the full-year FY2025 number at $19.3 million, down 14.46% from a year prior.
  • Raw Materials hit $19.3 million in Q2 2025 for Bioceres Crop Solutions, down from $22.5 million in the prior quarter.
  • Over the last five years, Raw Materials for BIOX hit a ceiling of $24.9 million in Q2 2023 and a floor of $3.3 million in Q4 2021.
  • Historically, Raw Materials has averaged $15.6 million across 5 years, with a median of $18.4 million in 2022.
  • Biggest five-year swings in Raw Materials: surged 177.42% in 2022 and later fell 14.46% in 2025.
  • Tracing BIOX's Raw Materials over 5 years: stood at $3.3 million in 2021, then skyrocketed by 429.58% to $17.5 million in 2022, then soared by 41.97% to $24.9 million in 2023, then dropped by 9.43% to $22.5 million in 2024, then dropped by 14.46% to $19.3 million in 2025.
  • Business Quant data shows Raw Materials for BIOX at $19.3 million in Q2 2025, $22.5 million in Q2 2024, and $24.9 million in Q2 2023.